Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 33 clinical trials
Featured trial
A Mobile Application for Telerehabilitation in Parkinson's Disease  

The purpose of this study is to determine if the 9zest app for Parkinson's disease is feasible, safe, and efficacious when used independently by individuals with Parkinson's disease.

brain stimulation
parkinson's disease
  • 20 views
  • 19 Feb, 2024
  • 1 location
Featured trial
Study to Evaluate DNL151 in Subjects With Parkinson's Disease  

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple oral doses of DNL151 in subjects with Parkinson's disease.

body mass index
parkinson's disease
  • 0 views
  • 19 Feb, 2024
  • 2 locations
Featured trial
A Study of Neurofeedback for the Treatment of Parkinson's Disease  

This study aims to reveal relationship between brain activities and the symptoms of Parkinson disease when a neurofeedback training was applied for them.

parkinson's disease
  • 0 views
  • 19 Feb, 2024
  • 1 location
Featured trial
Mundy Test 4.3 Study 1  

Mundy Test 4.3 Study 1 Overview details. Mundy Test 4.3 Study 1 Overview details. Mundy Test 4.3 Study 1 Overview details. Mundy Test 4.3 Study 1 Overview details.

Accepts healthy volunteers
  • 0 views
  • 19 Feb, 2024
  • 1 location
Nabilone for Non-motor Symptoms in Parkinson's Disease

This is an open-label extension study for participants of the randomized placebo-controlled, double-blind, parallel-group, enriched enrolment randomized withdrawal NMS-Nab Study, assessing the long-term safety and efficacy of nabilone for non-motor symptoms in patients with Parkinsons Disease. Nabilone is an analogue of tetrahydrocannabinol (THC), the psychoactive component of cannabis. Nabilone acts …

parkinson's disease
motor symptoms
  • 150 views
  • 19 Feb, 2024
  • 1 location
Lu AF28996 in Patients With Parkinson's Disease (PD)

The purpose of this study is to investigate the safety of Lu AF28996, how well it is tolerated and what the body does to the drug in Patients With Parkinson's Disease

mental state examination
benserazide
levodopa
mini-mental state examination
carbidopa
  • 0 views
  • 19 Feb, 2024
Apomorphine Pump in Early Stage of Parkinson's Disease (EARLY-PUMP)

The aim of the study is to assess the use of the apomorphine pump in earlier stages of Parkinson' Disease (PD), when motor complications have just developed and before patients are significantly affected in their social and occupational functioning.

dyskinesia
apomorphine
parkinsonism
medical therapy
parkinson's disease
  • 0 views
  • 19 Feb, 2024
Blood-Brain-Barrier Disruption With Cerezyme in Patient's With Parkinson's Disease

This clinical trial focus on the delivery of Cerezyme in Parkinson's Disease (PD) patients using MR-guided focused ultrasound (MRgFUS) induced opening of the blood-brain barrier (BBB).

parkinson's disease
  • 16 views
  • 19 Feb, 2024
Effects of Directional Subthalamic Deep Brain Stimulation on Gait and Balance in Parkinson's Disease Patients

Deep brain stimulation of the NST is effective for cardinal motor signs in patients with idiopathic Parkinson's disease (IPD), its effects on gait disturbances, especially freezing of gait-FOG, and falls are variable from one patient to another, in part depending on the location of the NST-stimulating contact.

tubal ligation
estrogen
brain stimulation
parkinson's disease
dopa
  • 0 views
  • 19 Feb, 2024
Application of LLM Care and Related Affective Computing Systems on People With Parkinson's Disease

The study is an adaptation of the Long Lasting Memories (LLM) (NCT02267499) and the subsequent LLM Care (NCT02313935) projects in patients with Parkinson's Disease (PD). The study aims to examine the viability and any potential benefits of cognitive and physical training, as offered via the ICT-based (non-pharmacological) intervention of LLM …

dyskinesia
chronic disease
diabetes
neurodegeneration
parkinson's disease
  • 0 views
  • 19 Feb, 2024